In HAT, mutations cause loss of function (LoF) in CREBBP and EP300, detected in about 35% of DLBCL patients with significantly high mutations seen in GCB-subtype [54,55]. Here, TMPRSS11D is linked to diffuse large B-cell lymphoma.